Table 2 Mortality in patients with and without ESRD who received CABG
ESRD (N = 48) | Non-ESRD (N = 96) | Adjusted HR (95% CI) | P value | |
|---|---|---|---|---|
Mortality (%) | 16 (33.33) | 11 (11.46) | 3.55 (1.64–7.69) | .001 |
Mortality with comorbidities (%) | ||||
Hypertension | ||||
Yes | 12 (25.00) | 10 (10.42) | 2.69 (1.16–6.26) | .022 |
No | 4 (8.33) | 1 (1.04) | 11.25 (1.25–101.16) | .031 |
Diabetes | ||||
Yes | 13 (27.08) | 9 (9.38) | 4.32 (1.78–10.47) | .001 |
No | 3 (6.25) | 2 (2.08) | 2.93 (0.49–17.57) | .240 |
Myocardial infarction | ||||
Yes | 8 (16.67) | 6 (6.25) | 3.68 (1.28–10.64) | .016 |
No | 8 (16.67) | 6 (6.25) | 3.64 (1.19–11.17) | .024 |
Stroke | ||||
Yes | 7 (14.58) | 3 (3.13) | 7.15 (1.45–5.23) | .016 |
No | 9 (18.75) | 8 (8.33) | 2.78 (1.07–7.21) | .035 |
Congestive heart failure | ||||
Yes | 9 (18.75) | 9 (9.38) | 2.26 (0.87–5.87) | .093 |
No | 7 (14.58) | 2 (2.08) | 10.11 (2.09–48.99) | .004 |
Peripheral arterial disease | ||||
Yes | 4 (8.33) | 2 (2.08) | 3.20 (0.59–17.51) | .179 |
No | 12 (25.00) | 9 (9.38) | 3.43 (1.44–8.17) | .005 |
COPD | ||||
Yes | 5 (10.42) | 3 (3.13) | 5.50 (1.29–23.53) | .021 |
No | 11 (22.92) | 8 (8.33) | 3.18 (1.28–7.93) | .013 |